The New York-based venture capital firm partners with universities and entrepreneurs to build biotech companies, with a particular focus on oncology, inflammatory, and autoimmune disease treatments. Orange Grove Bio aims to drive down the cost of drug discovery and accelerate the development of new therapies into clinical trials.